Microvascular and metabolic enzymes

Microvascular and metabolic enzymes refer to a heterogeneous group of enzymes that play critical roles in the intersection of metabolic regulation and microvascular health. This category is central to the pathogenesis of diabetic complications, where chronic hyperglycemia leads to the activation of pathological metabolic pathways—such as the polyol pathway, the hexosamine pathway, and the protein kinase C (PKC) pathway—resulting in microvascular damage [5, 6]. Key enzymes in this category include aldose reductase, which drives the polyol pathway; PKC isoforms, which mediate vascular inflammation and permeability; and angiotensin-converting enzyme (ACE), which regulates both vascular tone and insulin sensitivity [1, 2]. Therapeutic targeting of these enzymes aims to prevent or treat microvascular complications like retinopathy, nephropathy, and neuropathy by normalizing metabolic flux and restoring endothelial function [4, 5]. Additionally, enzymes like endothelial nitric oxide synthase (eNOS) and AMP-activated protein kinase (AMPK) are critical for maintaining microvascular tone and energy homeostasis in response to metabolic stimuli [2, 3].

Other names

Enzymes of microvascular complicationsMetabolic enzymes of the endotheliumPolyol pathway enzymesPKC pathway enzymesEndothelial metabolic enzymes

Modulation of metabolic flux through pathological pathways (e.g., polyol, hexosamine, PKC) and enhancement of protective pathways (e.g., eNOS, AMPK) to preserve microvascular integrity and function.